TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹9,607 Cr | ₹7,812 Cr | ₹7,364 Cr | ₹6,796 Cr | ₹6,077 Cr |
What is the latest Total Expenditure of TORRENT PHARMACEUTICALS ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹9,607 Cr |
| Mar2025 | ₹7,812 Cr |
| Mar2024 | ₹7,364 Cr |
| Mar2023 | ₹6,796 Cr |
| Mar2022 | ₹6,077 Cr |
How is Total Expenditure of TORRENT PHARMACEUTICALS Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹9,607 Cr | 22.98 | |
| Mar2025 | ₹7,812 Cr | 6.08 | |
| Mar2024 | ₹7,364 Cr | 8.36 | |
| Mar2023 | ₹6,796 Cr | 11.84 | |
| Mar2022 | ₹6,077 Cr | - | |
Compare Total Expenditure of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹163,223.9 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
| MANKIND PHARMA | ₹104,911.0 Cr | -0.3% | 7.9% | 8.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 4.3% |
11.2% |
42.5% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses